Drug-eluting resorbable scaffolds are superior to angioplasty for infrapopliteal artery disease

Nature Reviews Cardiology, Published online: 06 November 2023; doi:10.1038/s41569-023-00956-1In the LIFE-BTK trial, treatment with an everolimus-eluting resorbable scaffold was superior to angioplasty in improving clinical outcomes in patients with chronic limb-threatening ischaemia due to infrapopliteal artery disease.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Source Type: research